A new six-gene signature derived from weighted gene co-expression network analysis predicts breast cancer survival and ...

Recurring services and consumables, centralized high-throughput labs, automation, payer connectivity and outsourced testing support scale, efficiency and sustainable returns.Dublin, Oct. 16, 2026 ...

It’s natural after a miscarriage to ask, “Why did this happen?” While genetic testing is more commonly discussed after ...

OREM, UT, UNITED STATES, October 15, 2026 /EINPresswire.com/ -- Techcyte, developer of Fusion, the enterprise digital ...

Dublin, Oct. 13, 2026 (GLOBE NEWSWIRE) -- "Chromosomal Microarray Reflex Testing Global Market Report 2026" has been added to ResearchAndMarkets.com's offering. The global chromosomal microarray ...

Precision medicine, RNA sequencing, single-cell analysis and AI-driven genomics fuel adoption, while recurring consumables demand and North American leadership shape opportunitiesDublin, Oct. 07, 2026 ...

Researchers report that mitochondrial quality regulation gene activity defines two prognostically distinct breast cancer ...

Immunovia AB announced that a new analysis of PancreaSure® test performance has been published in the peer-reviewed Journal of Clinical Medicine. The analysis evaluated PancreaSure in individuals at ...

EpiSign Inc. and Geneyx Genomex Ltd. today announced a partnership to advance the integration of genomic and epigenomic ...

Doctors initially told the boy's parents not to worry. But they pressed for years until a rare diagnosis became clear.

GeneDx, the leader in rare disease diagnosis and improving health through the power of genomic data, today announced it will introduce Easy Order at the 2026 American Academy of Pediatrics (AAP) ...

EpiSign Inc. today announced the launch of EpiSign METRIC 5-base, extending its comprehensive and automated episignature analysis ...